ICH GCP - EU Clinical trials Registry

EudraCT Number: 2016-000869-23

Sponsor Protocol Number:

Start Date: 2017-03-17

Sponsor Name: The Institute of Cancer Research

Full Title: Targeting cancer care with the use of genetic profiling

Medical condition: Prostate Cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10062904	Hormone-refractory prostate cancer	PT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2019-000702-30

Sponsor Protocol Number: 18.021

Start Date: 2019-10-30

Sponsor Name: Odense University Hospital

Full Title: Fibromyalgia and Naltrexone: The FINAL study

Medical condition: Fibromyalgia

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10028395 - Musculoskeletal and connective tissue disorders	10048439	Fibromyalgia	PT

Population Age: Adults

Gender: Female

Trial protocol: DK (Ongoing)

Trial results: (No results available)

EudraCT Number: 2017-004506-18

Sponsor Protocol Number: LYMRIT-37-07

Start Date: 2018-06-13

Sponsor Name: Nordic Nanovector ASA

Full Title: A phase 2 open-label study of Betalutin in combination with rituximab in patients with relapsed/refractory follicular lymphoma (Archer-1)

Medical condition: Follicular lymphoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029547	Non-Hodgkin's lymphoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NO (Ongoing)

Trial results: (No results available)

EudraCT Number: 2019-003461-17

Sponsor Protocol Number: 71272

Start Date: 2020-01-07

Sponsor Name: Amsterdam UMC, location VUmc

Full Title: Pathophysiological relevance of IRON deficiency and related mitochondrial dysfunction in Heart Failure with Preserved Ejection Fraction (IRON-HFpEF)

Medical condition: Heart failure with preserved ejection fraction

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-003446-16

Sponsor Protocol Number: ATX-ME-001

Start Date: 2019-05-10

Sponsor Name: Achilles Therapeutics Limited

Full Title: An open-label, multi-centre, phase I/IIa study evaluating the safety and clinical activity of neoantigen reactive T cells in patients with metastatic or recurrent melanoma.

Medical condition: Metastatic or recurrent melanoma

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025650	Malignant melanoma	PT
	21.1	100000004865	10025651	Malignant melanoma excision	LLT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025652	Malignant melanoma in situ	PT
	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025670	Malignant melanoma stage III	PT
21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10025671	Malignant melanoma stage IV	PT
21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10053571	Melanoma	LLT
20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027148	Melanoma in situ	LLT
20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027150	Melanoma malignant	LLT
20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10066600	Melanoma recurrent	PT
21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027480	Metastatic malignant melanoma	PT
20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10027481	Metastatic melanoma	LLT
21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029488	Nodular melanoma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2018-004081-34

Sponsor Protocol Number: V.000369

Start Date: 2019-09-16

Sponsor Name:

Full Title: The effect of oxytocin on patient-physician relationships: a placebo controlled study

Medical condition: Healthy individuals

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-004148-53

Sponsor Protocol Number: M18ICR

Start Date: 2019-03-19

Sponsor Name: NKI-AVL

Full Title: ICRA (Improve Checkpoint-blockade Response in Advanced urothelial cancer), an adaptive clinical study to determine efficacy of combining weekly paclitaxel with tremelimumab +/- durvalumab (MEDI4736)

Medical condition: Metastatic urothelial carcinoma patients or patients with irresectable disease who were previously treated with chemotherapy - or are cisplatin-ineligible - and have progressed during or after trea...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004864	10022880	Invasive bladder cancer stage IV	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2017-003958-16

Sponsor Protocol Number: NL63056.018.17

Start Date: 2018-08-10

Sponsor Name: Academic Medical Center, University of Amsterdam

Full Title: Effect of Reslizumab on small airways in asthma. RESSAPEA

Medical condition: 1. Patients with severe eosinophilic asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004855	10068462	Eosinophilic asthma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-002564-10

Sponsor Protocol Number: AP-CL-OTHER-PI-12868

Start Date: 2019-04-23

Sponsor Name: Universitair Medisch Centrum Groningen

Full Title: Short-term safety, efficacy and mode of action of apremilast in mild to moderate cutaneous pemphigoid: a phase IIa open label single arm study.

Medical condition: Pemphigoid

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2018-003476-12

Sponsor Protocol Number: UMCU-VASC-CO-002

Start Date: 2019-09-12

Sponsor Name: University Medical Center Utrecht

Full Title: A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the effects of evolocumab added to standard lipid-lowering therapy on fasting and post fat load lipids in pa...

Medical condition: Familial Dysbetalipoproteinemia

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)